World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
18025
World Ranking
2691
National Ranking
1083

Marion G. Peters publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Marion G. Peters sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 256 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Marion G. Peters D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Marion G. Peters sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Marion G. Peters is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on the field of Medicine, with specific emphasis on Epidemiology, Hepatology, Infectious Diseases, Virology, and General Health Professions.

The main topics covered in their work include Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, Liver Disease and Transplantation, and HIV Research and Treatment.

Among recent publications, key papers authored or co-authored by Marion G. Peters are:

  • Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant (2020, American Journal of Transplantation)
  • Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis (2020, Clinical Gastroenterology and Hepatology)
  • Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015 (2021, JAMA Network Open)
  • Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update (2021, Clinical Gastroenterology and Hepatology)
  • Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America (2021, Hepatology)

Frequent co-authors in their research collaborations include:

  • Gregory D. Kirk
  • Keri N. Althoff
  • Edward R. Cachay
  • Richard D. Moore
  • Timothy R. Sterling

Marion G. Peters regularly publishes in the following venues:

  • UNC Libraries
  • Hepatology
  • Open Forum Infectious Diseases
  • Clinical Gastroenterology and Hepatology
  • Clinical Infectious Diseases

Best Publications

  • Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

    Hoofnagle Jh;Mullen Kd;Jones Db;Rustgi

  • Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

    Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins

  • Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

    Marion G. Peters;H. W. Hann;Paul Martin;E. Jenny Heathcote

  • Hepatitis B virus infection

    Man-Fung Yuen;Ding-Shinn Chen;Ding-Shinn Chen;Geoffrey M. Dusheiko;Harry L. A. Janssen

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

    Jay H. Hoofnagle;Jay H. Hoofnagle;Marion Peters;Marion Peters;Kevin D. Mullen;Kevin D. Mullen;D.Brian Jones;D.Brian Jones

  • Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

    Francis Y. Yao;Robert K. Kerlan;Ryutaro Hirose;Timothy J. Davern

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel

  • Viral Hepatitis in HIV Infection

    Margaret James Koziel;Marion G. Peters

  • In vivo expression of alternatively spliced forms of integrin-associated protein (CD47).

    M.I. Reinhold;F.P. Lindberg;D. Plas;S. Reynolds

  • Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

    Sharlene A. Teefey;Charles C. Hildeboldt;Farrokh Dehdashti;Barry A. Siegel

  • Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

    Jennifer Guy;Marion G. Peters

  • Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

    Priya Duggal;Chloe L. Thio;Genevieve L. Wojcik;James J. Goedert

  • Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

    Marion G. Peters;Janet Andersen;Patrick Lynch;Tun Liu

  • Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.

    Robert P. Perrillo;Fredric G. Regenstein;Marion G. Peters;Katherine DeSchryver-Kecskemeti

  • Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

    Vincent Soriano;Massimo Puoti;Marion Peters;Yves Benhamou

  • New Therapies for Hepatitis C Virus Infection

    Vincent Soriano;Marion G. Peters;Stefan Zeuzem

  • Immunology and the liver.

    Marion Peters;John Vierling;M. Eric Gershwin;David Milich

  • Actions of cytokines on the immune response and viral interactions: An overview

    M Peters

Frequent Co-Authors

Phyllis C. Tien
Phyllis C. Tien University of California, San Francisco
Raymond T. Chung
Raymond T. Chung Harvard University
Jay H. Hoofnagle
Jay H. Hoofnagle National Institutes of Health
Kenneth E. Sherman
Kenneth E. Sherman University of Cincinnati Medical Center
Chloe L. Thio
Chloe L. Thio Johns Hopkins University
Margaret James Koziel
Margaret James Koziel Harvard Medical School
Eric Carl Seaberg
Eric Carl Seaberg Johns Hopkins University
Mary Young
Mary Young Georgetown University
David L. Thomas
David L. Thomas Johns Hopkins University
Gregory D. Kirk
Gregory D. Kirk Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can open diverse career pathways. Public Health, for example, is a natural extension, and many universities offer mph online programs with easy admission requirements. These programs provide flexible options for those looking to expand their expertise in community health and disease prevention.

Another emerging field connected to microbiology is healthcare specialization. Careers like child specialists offer promising opportunities, and gaining insights into the child specialist salary can help prospective students evaluate the financial prospects of such roles.

Career pathways in healthcare are evolving to become more inclusive. For individuals with a criminal record, certain programs stand out as the best degree for felons, making higher education and professional growth more accessible than ever.

Additionally, the healthcare sector offers roles like functional medicine nurse practitioners, blending traditional and alternative approaches. Knowing the functional medicine np salary is crucial for those considering this innovative career path.

Overall, exploring these related degrees and career options can greatly enhance the prospects for anyone pursuing a future in microbiology or allied health fields.

Best Scientists Citing Marion G. Peters

Trending Scientists